Benefits of Trimetazidine in MASLD Patients

Clinical trial NCT06140953 · COMPLETED

Trial details

NCT number: NCT06140953
Sponsor: October 6 University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metabolic Associated Fatty Liver Disease

Start date: 2023-12-10
Primary completion: 2024-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.